|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pasechnikov V, Chukov S, Fedorov E,
Kikuste I and Leja M: Gastric cancer: Prevention, screening and
early diagnosis. World J Gastroenterol. 20:13842–13862. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen F, Cai WS, Feng Z, Li JL, Chen JW,
Cao J and Xu B: MiR-492 contributes to cell proliferation and cell
cycle of human breast cancer cells by suppressing SOX7 expression.
Tumour Biol. 36:1913–1921. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang X, Ke X, Pu Q, Yuan Y, Yang W, Luo
X, Jiang Q, Hu X, Gong Y, Tang K, et al: MicroRNA-410 acts as
oncogene in NSCLC through downregulating SLC34A2 via activating
Wnt/β-catenin pathway. Oncotarget. 7:14569–14585. 2016.PubMed/NCBI
|
|
5
|
Cheng CM, Shiah SG, Huang CC, Hsiao JR and
Chang JY: Up-regulation of miR-455-5p by the TGF-β-SMAD signalling
axis promotes the proliferation of oral squamous cancer cells by
targeting UBE2B. J Pathol. 240:38–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan A, Yang C, Chen Z, Li C and Cai L:
MiR-761 promotes progression and metastasis of non-small cell lung
cancer by targeting ING4 and TIMP2. Cell Physiol Biochem. 37:55–66.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou X, Zhang L, Zheng B, Yan Y, Zhang Y,
Xie H, Zhou L, Zheng S and Wang W: MicroRNA-761 is upregulated in
hepatocellular carcinoma and regulates tumorigenesis by targeting
Mitofusin-2. Cancer Sci. 107:424–432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi C and Zhang Z: miR-761 inhibits tumor
progression by targeting MSI1 in ovarian carcinoma. Tumour Biol.
37:5437–5443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yao K, He L, Gan Y, Zeng Q, Dai Y and Tan
J: MiR-186 suppresses the growth and metastasis of bladder cancer
by targeting NSBP1. Diagn Pathol. 10:1462015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei P, Qiao B, Li Q, Han X, Zhang H, Huo Q
and Sun J: MicroRNA-340 suppresses tumorigenic potential of
prostate cancer cells by targeting high-mobility group
nucleosome-binding domain 5. DNA Cell Biol. 35:33–43. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Liu K, Li T, Fang J, Ding Y, Sun
L, Tu T, Jiang X, Du S, Hu J, et al: miR-21: A gene of dual
regulation in breast cancer. Int J Oncol. 48:161–172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng D, Wang L, Chen Y, Li B, Xue L, Shao
N, Wang Q, Xia X, Yang Y and Zhi F: MicroRNA-124-3p regulates cell
proliferation, invasion, apoptosis, and bioenergetics by targeting
PIM1 in astrocytoma. Cancer Sci. 107:899–907. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song H, Zhang Y, Liu N, Wan C, Zhang D,
Zhao S, Kong Y and Yuan L: miR-92b regulates glioma cells
proliferation, migration, invasion, and apoptosis via PTEN/Akt
signaling pathway. J Physiol Biochem. 72:201–211. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu YC, Chang JT, Chan EC, Chao YK, Yeh TS,
Chen JS and Cheng AJ: miR-196, an emerging cancer biomarker for
digestive tract cancers. J Cancer. 7:650–655. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang F, Li B and Xie X: The roles and
clinical significance of microRNAs in cervical cancer. Histol
Histopathol. 31:131–139. 2016.PubMed/NCBI
|
|
17
|
Zhai R, Kan X, Wang B, Du H, Long Y, Wu H,
Tao K, Wang G, Bao L, Li F and Zhang W: miR-152 suppresses gastric
cancer cell proliferation and motility by targeting CD151. Tumour
Biol. 35:11367–11373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang M, Cui G, Ding M, Yang W, Liu Y, Dai
D and Chen L: miR-935 promotes gastric cancer cell proliferation by
targeting SOX7. Biomed Pharmacother. 79:153–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu W, Gao T, Shen J, Sun Y, Zheng X, Wang
J, Ma J, Hu XY, Li J and Hu MJ: MicroRNA-183 inhibits apoptosis and
promotes proliferation and invasion of gastric cancer cells by
targeting PDCD4. Int J Clin Exp Med. 7:2519–2529. 2014.PubMed/NCBI
|
|
20
|
Taelman VF, Dobrowolski R, Plouhinec JL,
Fuentealba LC, Vorwald PP, Gumper I, Sabatini DD and De Robertis
EM: Wnt signaling requires sequestration of glycogen synthase
kinase 3 inside multivesicular endosomes. Cell. 143:1136–1148.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li T, Lai Q, Wang S, Cai J, Xiao Z, Deng
D, He L, Jiao H, Ye Y, Liang L, et al: MicroRNA-224 sustains
Wnt/β-catenin signaling and promotes aggressive phenotype of
colorectal cancer. J Exp Clin Cancer Res. 35:212016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng W, Wang J, Zhang J, Cai J, Bai Z and
Zhang Z: Orai1, a direct target of microRNA-519, promotes
progression of colorectal cancer via Akt/GSK3β signaling pathway.
Dig Dis Sci. 61:1553–1560. 2016. View Article : Google Scholar : PubMed/NCBI
|
